Modified poly-L-lysine for use as a clearing agent in pretargeted radioimmunotherapy

• Päätekijät: Chiara Timperanza (Tekijä), Anna Gustafsson-Lutz (Tekijä), Tom Bäck (Tekijä), Damian J. Green (Tekijä), Sture Lindegren (Tekijä), Emma Aneheim (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SpringerOpen, 2024-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Background Pretargeted radioimmunotherapy of cancer has the potential to increase tumor specific uptake of activity when compared with conventional radioimmunotherapy. This is especially true in radioimmunotherapy with nuclides that exhibit a relatively short half-life. When administering a...